CLINICAL_TRIALS
trial_result
· 2024-04-19
Clinical Trial Update: Therapeutic Effect of PBF-680 in Patients With COPD [Phase 2]
Summary
Phase 2 clinical trial update on PBF-680 for chronic obstructive pulmonary disease (COPD) has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Palobiofarma SL | Conditions: COPD | Phase 2 | Status: COMPLETED